Researchers conducted a systematic review and reanalysis of studies gathered from six major databases and conference abstracts. They used effective practice and organization of care quality criteria to analyze the studies. They identified 76 studies assessing interventions for carbapenem-resistant Enterobacteriaceae (CRE), carbapenem-resistant Acinetobacter baumannii (CRAB) and carbapenem-resistant Pseudomonas aeruginosa (CRPsA).
The study shows interventions were implemented using a multimodal approach in
• 10 of 11 CRE-focused studies
• Four of five CRAB-focused studies
• Three of three CRPsA-focused studies
The most frequent intervention components included:
• Contact precautions: 90 percent
• Active surveillance cultures: 80 percent
• Monitoring, audit and feedback of measures: 80 percent
• Patient isolation or cohorting: 70 percent
• Hand hygiene: 50 percent
• Environmental cleaning: 40 percent
More articles on healthcare quality:
Physicians find link between heroin use, spinal infections
74% of adults report barriers to traveling for specialty cancer care
Indiana VA hospital unveils building for sterilizing surgical tools, remodeled 4th floor
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
